[UPDATE, August 1, 2018: Abacus and Expensify agreed to dismiss all claims. More information here.]
[UPDATE, Aug. 18, 2017: Abacus Labs Inc. asked the U.S. District Court for the Southern District of New York to dismiss Expensify's claims because, Abacus argued, the patents in question are not valid. "These patents are directed to the abstract idea of correlating unreadable information in a financial record to another document from the same transaction," attorneys wrote. "No new technology is claimed or described in the . . .